parkinson
diseas
pd
progress
neurodegen
diseas
character
bradykinesia
rest
tremor
postur
instabl
rigid
diseas
affect
global
popul
age
brain
patient
pd
loss
dopamineproduc
neuron
substantia
nigra
par
compacta
snpc
striatum
st
may
occur
even
prior
onset
symptom
neurodegener
avail
treatment
work
reliev
symptom
pd
increas
dopaminerg
signal
one
three
mechan
increas
dopamin
level
increas
level
biosynthet
precursor
ldopa
block
breakdown
dopamin
inhibit
metabol
enzym
monoamin
oxidas
catecholomethyltransferas
mimick
activ
dopamin
directli
agon
dopamin
receptor
howev
still
unmet
clinic
need
develop
mechanismbas
andor
diseasemodifi
medic
treat
symptom
progress
pd
nuclear
receptorrel
protein
transcript
factor
regul
express
gene
critic
develop
mainten
surviv
dopaminerg
neuron
particular
play
fundament
role
maintain
dopamin
homeostasi
regul
transcript
gene
govern
dopamin
synthesi
packag
reuptak
also
regul
surviv
dopaminerg
neuron
stimul
transcript
gene
code
neurotroph
factor
antiinflammatori
respons
oxid
stress
mitochondri
dysfunct
manag
well
repress
transcript
express
proinflammatori
gene
lack
embryon
ventral
midbrain
cell
hinder
migrat
striatal
area
microglia
astrocyt
repress
proinflammatori
respons
protect
dopaminerg
neuron
inflammationinduc
neuron
toxic
death
midbrain
patient
pd
express
reduc
compar
agematch
control
yet
rare
polymorph
appear
associ
diseas
stimul
activ
may
combat
reduc
dopamin
level
increas
oxid
stress
inflamm
associ
pd
togeth
find
strongli
suggest
disrupt
functionexpress
relat
neurodegener
dopaminerg
neuron
allevi
inflamm
mitochondri
dysfunct
therebi
may
improv
pathogenesi
pd
cicadida
periostracum
cp
castoff
skin
cryptotympana
pustulata
fabriciu
also
known
cicada
sunta
origin
describ
chungbu
categori
dongui
bogam
ancient
korean
medic
book
korean
tradit
medicin
cp
use
treat
epilepsi
shock
smallpox
sedat
edema
night
terror
symptom
tradit
chines
medicin
cp
known
chantui
long
use
treat
sore
throat
hoars
itch
spasm
symptom
sinc
use
tradit
medicin
mani
pharmacolog
effect
world
health
organ
intern
expert
meet
review
analyz
clinic
report
sever
acut
respiratori
syndrom
sar
treatment
note
chines
use
combin
cicada
silkworm
drop
treat
sarsassoci
fever
recent
sever
studi
confirm
pharmacolog
effect
cp
includ
antiskin
age
antikidney
injuri
anticonvuls
sed
antiallergi
antianaphylact
shock
action
howev
scientif
evid
use
cp
neurodegen
diseas
includ
pd
lack
therefor
studi
investig
protect
effect
cp
mptp
induc
neurotox
mice
explor
underli
mechan
action
focus
cp
purchas
kwongmungdang
compani
ulsan
korea
authent
dr
goya
choi
herbal
medicin
resourc
research
center
korea
institut
orient
medicin
naju
korea
voucher
specimen
deposit
herbal
medicin
resourc
research
center
korea
institut
orient
medicin
briefli
cp
extract
distil
water
h
reflux
extract
filter
evapor
rotari
vacuum
evapor
lyophil
yield
powder
kept
use
male
mice
week
g
purchas
doo
yeol
biotech
seoul
korea
maintain
temperatur
lightcontrol
condit
h
h
dark
cycl
food
water
provid
ad
libitum
anim
acclimat
day
prior
drug
administr
experiment
protocol
approv
institut
anim
care
committe
kiom
perform
accord
guidelin
anim
care
use
committe
kiom
mice
assign
group
control
n
mptp
n
mptpcp
mgkgday
n
mptpcp
mgkgday
n
mptpcp
mgkgday
n
mptpropinirol
mgkgday
n
cp
mgkgday
n
cp
mgkgday
n
control
n
lipopolysaccharid
lp
n
lpscp
mgkgday
n
cp
dissolv
normal
salin
administ
day
consecut
control
group
receiv
equal
volum
normal
salin
durat
mptp
sigmaaldrich
st
loui
mo
usa
lp
sigmaaldrich
administ
acut
describ
previous
day
cp
treatment
mptp
mgkg
dissolv
salin
inject
intraperiton
four
time
h
interv
vehicl
equal
volum
ml
given
control
group
figur
lp
group
h
last
administr
cp
lp
dissolv
salin
inject
intraperiton
dose
mgkg
figur
b
sinc
mptp
danger
chemic
conduct
experi
complianc
previous
describ
procedur
use
laboratori
cloth
boot
made
nonabsorb
materi
wore
mask
hepa
filter
bleach
use
clean
equip
use
experi
wast
dispos
biohazard
safeti
bin
rotarod
test
pole
test
assess
accord
previous
publish
method
rotarod
test
use
method
measur
hypokinesia
mous
model
pd
mice
evalu
rotarod
day
last
mptp
inject
assess
sensorimotor
coordin
rotarod
unit
ugo
basil
comerio
vares
itali
consist
rotat
spindl
diamet
cm
five
individu
compart
allow
five
mice
test
simultan
two
success
day
twicedaili
train
rpm
rotat
speed
first
day
rpm
second
day
test
rotat
speed
increas
rpm
third
day
test
session
time
mous
remain
rotat
bar
record
three
trial
per
mous
min
interv
maximum
trial
length
per
trial
data
present
mean
time
rotat
bar
three
test
trial
pole
test
use
method
measur
bradykinesia
mous
model
pd
perform
pole
test
day
last
mptp
inject
mice
held
top
pole
diamet
mm
height
cm
rough
surfac
time
mice
need
turn
complet
record
time
turn
tturn
time
need
mice
climb
place
four
feet
floor
record
time
locomot
activ
tla
trial
cutoff
limit
day
one
seven
mptp
treatment
h
lp
treatment
mice
anesthet
immedi
perfus
transcardi
phosphatebuff
salin
pb
sigmaaldrich
follow
cold
paraformaldehyd
pfa
sigmaaldrich
phosphat
buffer
brain
remov
postfix
phosphat
buffer
sigmaaldrich
contain
pfa
overnight
immers
solut
contain
sucros
pb
cryoprotect
serial
thick
coron
section
cut
freez
microtom
leica
instrument
gmbh
nussloch
germani
store
cryoprotect
ethylen
glycol
sigmaaldrich
glycerol
sigmaaldrich
phosphat
buffer
use
immunohistochemistri
ihc
studi
western
blot
mrna
analysi
kitbas
analys
brief
snpc
st
rapidli
dissect
homogen
centrifug
use
standard
laboratori
techniqu
final
supernat
store
use
ihc
analysi
assess
dopaminerg
neuron
snpc
made
analyz
coron
section
approxim
mm
behind
bregma
brain
section
rins
briefli
pb
treat
hydrogen
peroxid
sigmaaldrich
min
section
incub
rabbit
antityrosin
hydroxylas
th
overnight
presenc
triton
vector
laboratori
burlingam
ca
usa
normal
goat
serum
vector
laboratori
normal
hors
serum
vector
laboratori
rins
pb
section
incub
biotinyl
antirabbit
igg
vector
laboratori
min
rins
incub
abc
vector
laboratori
h
room
temperatur
peroxidas
activ
visual
incub
section
dab
sigmaaldrich
trisbuff
salin
sigmaaldrich
sever
rins
pb
section
mount
gelatinco
slide
dehydr
coverslip
use
histomount
medium
immunofluoresc
analysi
brain
section
rins
briefli
pb
treat
bsa
sigmaaldrich
min
section
incub
mous
antith
rabbit
antigli
fibrillari
acid
protein
gfap
ioniz
calciumbind
adaptor
molecul
cyclooxygenas
cox
overnight
presenc
triton
normal
serum
next
incub
h
alexa
fluorconjug
secondari
antibodi
section
final
wash
pb
mount
use
vectashield
mount
medium
contain
dapi
vector
laboratori
imag
photograph
magnif
use
optic
light
microscop
olympu
microscop
system
olympu
tokyo
japan
equip
object
len
analyz
intens
striatal
thposit
nerv
fiber
brain
section
sampl
approxim
mm
ahead
bregma
primari
antibodi
list
supplementari
homogen
snpc
tissu
conduct
use
trizol
reagent
invitrogen
carlsbad
ca
usa
homogen
ml
chloroform
ad
sampl
tube
shaken
vigor
hand
incub
room
temperatur
min
next
mixtur
centrifug
rpm
min
result
upper
aqueou
phase
transfer
fresh
tube
ml
also
ad
incub
min
mixtur
centrifug
rpm
min
separ
supernat
remov
wash
ml
ethanol
centrifug
rpm
min
result
rna
pellet
dri
purifi
rna
dissolv
diethyl
pyrocarbon
depc
distil
water
equal
amount
rna
ng
revers
transcrib
rt
cdna
use
iscript
cdna
synthesi
kit
biorad
hercul
ca
unit
state
accord
manufactur
protocol
realtim
rt
polymeras
chain
reaction
pcr
analysi
perform
select
gene
use
realtim
pcr
system
biorad
sybr
green
fluoresc
quantif
system
biorad
quantifi
amplicon
pcr
condit
cycl
standard
denatur
curv
primer
sequenc
list
orient
supplementari
pcr
condit
target
optim
accord
primer
concentr
absenc
primer
dimer
format
effici
amplif
target
gene
housekeep
control
gene
pcr
reaction
mixtur
compris
cdna
pcr
master
mix
contain
sybr
green
pmol
forward
revers
primer
depcdistil
water
final
volum
normal
cdna
content
sampl
use
compar
threshold
ct
cycl
method
includ
normal
number
target
gene
copi
vs
endogen
refer
gene
glyceraldehyd
dehydrogenas
ct
defin
fraction
cycl
number
fluoresc
gener
cleavag
probe
pass
fix
threshold
baselin
amplif
pcr
product
first
detect
pheochromocytoma
cell
line
deriv
rat
adren
medulla
obtain
korean
cell
line
bank
cell
maintain
roswel
park
memori
institut
medium
gibco
md
usa
supplement
heatinactiv
fetal
bovin
serum
gibco
penicillinstreptomycin
gibco
atmospher
air
cell
seed
plate
plate
densiti
cellsml
treat
cp
h
figur
c
differenti
cultur
media
renew
everi
day
cultur
cell
treat
nerv
growth
factor
sigmaaldrich
day
fresh
medium
reagent
suppli
everi
h
differenti
cell
treat
cp
h
stimul
mpp
addit
h
figur
mous
microgli
cell
line
kindli
donat
prof
jung
seoul
nation
univers
hospit
korea
cell
kept
dulbecco
modifi
eagl
medium
gibco
supplement
heatinactiv
fetal
bovin
serum
penicillinstreptomycin
atmospher
air
cell
seed
plate
densiti
cellsml
treat
cp
h
figur
c
live
cell
evalu
use
cell
count
kit
dojindo
kumamoto
japan
accord
manufactur
protocol
brief
cell
seed
plate
treat
cp
reagent
ad
well
mixtur
incub
h
absorb
read
nm
use
spectramax
multimod
detect
platform
molecular
devic
sunnyval
ca
usa
cell
viabil
calcul
use
follow
equat
live
cell
left
cp
treatment
mean
absorb
cp
treat
cellsmean
absorb
untreat
control
western
blot
perform
accord
previous
publish
method
moreov
monitor
lipophil
cation
probe
tetraethylbenzimidazolylcarbocyanin
iodid
reagent
suppli
detect
kit
accord
manufactur
instruct
differenti
cell
seed
coverslip
plate
treat
simultan
cp
concentr
mpp
h
cell
rins
pb
incub
dilut
lipophil
cation
probe
iodid
min
cell
wash
transfer
plate
ratio
red
nm
green
nm
fluoresc
determin
use
fluoresc
plate
reader
differenti
cell
use
confluenc
mm
dish
cell
transfect
stealth
small
interf
rna
sirna
use
lipofectamin
invitrogen
lipofectamin
mix
sirna
solut
equimolar
mix
sirna
scrambl
sirna
ml
optimem
gibco
min
room
temperatur
mix
ad
serumfre
rpmi
dish
incub
h
dopamin
content
st
mous
brain
assess
use
commerci
avail
fluorometr
assay
kit
follow
protocol
suppli
manufactur
rocki
mountain
diagnost
moreov
cytokin
protein
determin
use
cytokin
membran
array
kit
follow
manufactur
instruct
r
system
minneapoli
mn
usa
statist
paramet
calcul
use
graphpad
prism
softwar
graphpad
softwar
san
diego
ca
usa
valu
express
mean
standard
error
mean
sem
statist
comparison
differ
treatment
perform
use
oneway
analysi
varianc
anova
tukey
multipl
comparison
posttest
p
valu
consid
statist
signific
examin
effect
cp
mptpinduc
poor
motor
coordin
postur
balanc
rotarod
test
perform
found
mptp
significantli
decreas
retent
time
day
compar
control
howev
retent
time
significantli
increas
mgkgday
cp
ropinirol
group
respect
day
figur
addit
evalu
effect
cp
mptpinduc
bradykinesia
pole
test
perform
tturn
tla
significantli
prolong
respect
day
compar
control
howev
tturn
significantli
shorten
mgkgday
cp
ropinirol
group
respect
day
howev
tla
significantli
shorten
mgkgday
cp
ropinirol
group
respect
day
figur
b
c
tturn
tla
significantli
prolong
respect
day
compar
control
howev
tturn
tla
significantli
shorten
mptp
mgkgday
cp
group
respect
day
figur
e
confirm
effect
cp
dopaminerg
neuron
death
perform
thspecif
immunohistochemistri
snpc
st
mous
brain
mptptreat
mice
number
thposit
cell
snpc
optic
intens
st
decreas
respect
compar
control
group
howev
valu
significantli
increas
mgkg
cp
ropinirol
treatment
respect
compar
control
group
figur
b
e
moreov
measur
effect
cp
dopamin
level
determin
striatal
dopamin
level
st
mous
brain
figur
c
treatment
mptp
significantli
decreas
striatal
dopamin
nmolml
compar
control
group
treatment
mgkg
cp
ropinirol
reduc
mptpinduc
striatal
dopamin
nmolml
nmolml
moreov
treatment
mgkg
cp
increas
striatal
dopamin
nmolml
compar
control
group
figur
c
also
investig
effect
cp
maob
activ
selegilin
posit
control
inhibit
maob
activ
dosedepend
manner
contrast
cp
effect
maob
activ
figur
treatment
cp
increas
neuron
shrinkag
damag
decreas
dendrit
length
differenti
cell
h
treatment
figur
b
thu
experi
perform
cp
investig
effect
cp
regul
protein
determin
level
th
ddc
dat
differenti
cell
protein
express
level
th
ddc
dat
increas
h
cp
treatment
th
ddc
dat
compar
control
group
figur
c
f
j
confirm
effect
cp
regul
protein
mous
snpc
th
ddc
dat
compar
control
group
figur
f
j
investig
whether
erk
activ
contribut
cpinduc
increas
express
use
select
inhibitor
erk
inhibit
cpinduc
increas
th
ddc
dat
differenti
cell
th
ddc
dat
compar
control
group
figur
e
f
j
evalu
effect
cp
express
perform
immunofluoresc
stain
western
blot
mptp
significantli
decreas
shrunken
dopaminerg
neuron
compar
control
treatment
mgkg
cp
reduc
mptpinduc
dopaminerg
neuron
figur
c
moreov
confirm
express
level
western
blot
mptp
significantli
decreas
snpc
compar
control
treatment
mgkg
cp
reduc
mptpinduc
figur
repres
photomicrograph
taken
doublelabel
immunofluoresc
stain
antith
antibodi
snpc
figur
c
supplementari
fig
evalu
effect
cp
mptpinduc
express
regul
protein
assess
level
th
ddc
dat
mous
snpc
western
blot
mptp
significantli
decreas
th
ddc
dat
level
compar
control
treatment
mgkg
cp
reduc
mptpinduc
express
th
ddc
dat
compar
control
group
figur
h
addit
measur
mrna
express
level
regul
protein
use
realtim
rtpcr
analysi
mptp
significantli
decreas
th
dat
level
treatment
mgkg
cp
reduc
mptpinduc
express
th
dat
figur
moreov
verifi
whether
cpinduc
th
dat
mediat
activ
transfect
differenti
cell
sirna
target
result
show
th
dat
level
affect
cp
sirnatransfect
cell
figur
e
investig
whether
cp
affect
mitochondri
dysfunct
mitochondriamedi
apoptosi
assess
mitochondri
membran
potenti
differenti
cell
level
bax
cytc
poli
adpribos
polymeras
parp
cleav
cleav
mous
snpc
mptp
caus
signific
decreas
increas
bax
cytc
parp
cleav
cleav
mgkg
cp
increas
decreas
bax
cytc
parp
cleav
cleav
figur
green
fluoresc
monomer
form
low
red
fluoresc
aggreg
form
high
indic
depolar
mppinduc
toxic
decreas
ratio
wherea
cp
pretreat
prevent
depolar
mitochondri
membran
ratio
figur
b
c
investig
whether
cp
affect
dopaminerg
product
assess
level
gdnf
ret
mous
snpc
mptp
significantli
decreas
express
gdnf
ret
mgkg
cp
treatment
increas
level
gdnf
ret
figur
use
enzymelink
immunosorb
assay
elisa
kit
found
mptp
decreas
gdnf
snpc
pgml
st
pgml
treatment
mgkg
cp
reduc
mptpinduc
express
gdnf
snpc
pgml
st
pgml
figur
e
investig
whether
cp
affect
neuroinflammatori
respons
assess
glialmicrogli
activ
level
neuroinflammatori
factor
microgli
cell
mous
snpc
measur
express
level
gfap
ino
releas
follow
inflammatori
stimuli
western
blot
western
blot
analysi
reveal
level
gfap
ino
significantli
increas
respect
snpc
mptptreat
group
contrast
cp
suppress
decreas
gfap
ino
respect
figur
f
repres
photomicrograph
taken
immunofluoresc
stain
gfap
antibodi
snpc
figur
b
g
microgli
cell
cytotox
affect
cp
assess
mtt
assay
h
treatment
howev
cp
increas
cytotox
data
shown
thu
experi
perform
cp
cytokin
array
kit
reveal
level
intercellular
adhes
molecul
kc
rant
significantli
increas
respect
lpstreat
microgli
cell
contrast
cp
suppress
increas
kc
monocyt
chemotact
protein
rant
respect
figur
f
level
ino
also
significantli
increas
respect
snpc
lpstreat
group
moreov
cp
treatment
suppress
increas
ino
figur
g
h
mani
intrins
signal
extrins
transcript
factor
identifi
play
critic
role
dopaminerg
neuron
develop
midbrain
pd
process
depend
two
major
signal
pathway
sonic
ii
winglesstyp
mmtv
integr
site
famili
member
downstream
signal
molecul
two
signal
pathway
merg
control
express
level
suggest
key
regul
dopaminerg
neuron
inde
dopaminerg
neuron
fail
develop
mice
lack
receptor
use
vosview
softwar
visual
network
similar
found
cluster
keyword
across
public
relat
alzheim
diseas
patholog
pd
dopaminerg
neuron
gdnf
alphasynuclein
canon
ligandbind
pocket
cilostazol
supplementari
fig
result
led
us
think
may
promis
target
treatment
pd
accord
much
world
popul
reli
primarili
anim
plantbas
medicin
animalassist
therapi
known
zootherapi
zt
phenomenon
zt
mark
broad
geograph
distribut
deep
histor
origin
despit
import
studi
zt
neglect
compar
plantbas
therapi
howev
modern
societi
zt
constitut
import
altern
therapi
practic
worldwid
wild
domest
anim
byproduct
eg
hoov
skin
bone
feather
tusk
provid
import
ingredi
cur
protect
prevent
medicin
recent
increas
interest
animalbas
medicin
sever
anim
test
pharmaceut
compani
potenti
sourc
modern
drug
base
previou
studi
screen
korean
tradit
medicin
librari
compos
clinic
use
drug
chungbu
categori
dongui
bogam
identifi
one
hit
drug
previou
report
show
promot
dopaminerg
neuron
develop
induc
express
neurotroph
factor
th
ddc
dat
dopamin
transport
synapt
vesicl
major
factor
maintain
dopamin
homeostasi
dopaminerg
presynapt
termin
also
demonstr
gene
express
peripher
blood
lymphocyt
patient
pd
decreas
compar
healthi
peopl
present
studi
cp
increas
level
regul
protein
th
ddc
dat
differenti
cell
mous
snpc
moreov
knockdown
use
sirna
block
cpmediat
increas
th
dat
protein
express
suggest
activ
crucial
cpinduc
th
dat
upregul
recent
studi
shown
two
region
ntermin
ctermin
region
import
transcript
activ
nterminu
import
regul
transcript
mitogenactiv
protein
kinas
mapk
depend
manner
report
phosphoryl
transloc
nucleu
upregul
th
express
present
studi
erk
inhibitor
inhibit
cpinduc
increas
th
ddc
dat
differenti
cell
also
found
cp
regul
striatal
dopamin
level
mous
st
maob
mainli
involv
dopamin
metabol
confirm
diseasemodifi
action
cp
could
ascrib
prevent
convers
mptp
mpp
also
measur
activ
maob
howev
cp
effect
maob
activ
result
suggest
cp
increas
neurotroph
factor
upregul
express
via
erk
phosphoryl
recent
suggest
induc
exert
neuroprotect
effect
experiment
model
pd
thu
possibl
futur
therapeut
strategi
pd
may
includ
induc
signal
cp
abovedescrib
find
prompt
us
test
whether
cp
amelior
motor
behavior
deficit
mous
model
mptpinduc
pd
anim
model
use
wide
dopaminerg
neuron
loss
snpc
st
associ
onset
motor
symptom
direct
relationship
extent
dopamin
loss
motor
dysfunct
pole
test
assess
anim
agil
includ
measur
muscl
rigid
bradykinesia
rotarod
test
use
assess
motor
coordin
postur
balanc
pole
test
cptreat
mice
show
signific
improv
tturn
tla
measur
similar
control
group
addit
rotarod
test
cp
prolong
durat
spent
mice
rotarod
similar
studi
hsieh
et
al
report
cp
increas
hypomotil
induc
th
inhibitor
precursor
serotonin
moreov
result
show
cp
significantli
increas
mptpinduc
dopamin
level
cp
stabil
central
catecholaminerg
serotonerg
activ
expect
effect
variou
disord
convuls
insomnia
therefor
think
need
focu
studi
catecholamin
behavior
chang
furthermor
confirm
effect
thspecif
ihc
demonstr
cp
protect
dopaminerg
neuron
snpc
fiber
st
compar
mice
treat
mptp
present
studi
number
doubleposit
neuron
regul
protein
snpc
declin
mptp
group
compar
control
group
coloc
express
level
increas
cptreat
group
gdnf
canon
receptor
ret
signal
togeth
independ
fulfil
mani
import
function
midbrain
dopaminerg
system
ret
downstream
target
found
transcript
downregul
accumul
reduc
ret
protein
level
might
prevent
gdnfinduc
surviv
respons
midbrain
dopaminerg
neuron
thu
rational
link
gdnfret
signal
anoth
protein
found
mutat
rare
famili
form
pd
autosom
recess
lossoffunct
mutat
studi
cp
significantli
protect
mptpinduc
gdnfret
signal
mice
taken
togeth
present
studi
show
cp
significantli
improv
mptpinduc
pdlike
movement
problem
protect
dopaminerg
neuron
damag
neurotroph
respons
activ
mous
dopaminerg
neuron
final
proapoptot
well
antiapoptot
effect
also
analyz
effect
cp
mitochondri
dysfunct
mitochondriamedi
apoptosi
protein
famili
contain
key
apoptosisregul
protein
promot
cell
surviv
induc
cell
death
appear
directli
indirectli
preserv
integr
outer
mitochondri
membran
thu
prevent
cytc
releas
mitochondriamedi
cell
death
initi
hand
proapoptot
protein
bax
promot
cytc
releas
mitochondria
subsequ
cleav
parp
recent
shown
downregul
express
proapoptot
protein
bax
directli
transactiv
tumor
suppressor
microarray
analysi
reveal
overexpress
downregul
cleav
apoptot
factor
neural
stem
cell
studi
mptp
induc
slight
decreas
express
increas
bax
express
cp
protect
chang
moreov
mptpinduc
toxic
increas
cytc
wherea
cp
inhibit
cytc
releas
induct
cytcmedi
cleav
parp
level
proapoptot
agent
includ
mptp
appear
essenti
apoptosi
treatment
cp
prevent
mptpinduc
increas
cleav
parp
level
antiapoptot
effect
associ
pro
well
antiinflammatori
respons
also
check
effect
cp
proinflammatori
cytokin
signal
molecul
moreov
xu
et
al
demonstr
cp
decreas
inflammatoryrel
protein
ino
lpsinduc
raw
macrophag
cell
moreov
accord
chang
et
al
cp
inhibit
inflammationrel
protein
via
modul
reactiv
oxygen
speci
induc
ultraviolet
b
irradi
keratinocyt
hacat
cell
therefor
possibl
antiinflammatori
effect
studi
cp
repress
neuroinflammatori
signal
molecul
ino
glialmicrogli
activ
mptp
lpstreat
mice
moreov
microgli
cell
treat
inflammationinduc
lp
h
express
proinflammatori
gene
cytokin
array
gcsf
gmcsf
itac
kc
mcsf
rant
tarc
increas
remark
cp
reduc
express
kc
rant
howev
studi
use
transgen
mice
requir
confirm
find
next
analyz
proteinprotein
interact
use
string
databas
potenti
molecular
mechan
use
kegg
databas
supplementari
fig
found
function
relationship
among
protein
primarili
relat
inflammatori
neuron
death
mechan
includ
smallcel
lung
cancer
tuberculosi
agerag
signal
pathway
diabet
complic
apoptosi
amyotroph
later
sclerosi
hepat
b
influenza
platinum
drug
resist
pathway
cancer
colorect
cancer
kaposi
sarcomaassoci
herpesviru
infect
toxoplasmosi
tnf
signal
pathway
pd
legionellosi
signal
pathway
taken
togeth
data
show
cp
enhanc
dual
role
cp
increas
express
regul
protein
dopaminerg
neuron
ii
inhibit
mitochondriamedi
apoptosi
proinflammatori
cytokin
gene
express
studi
limit
first
investig
effect
cp
mptpinduc
pd
mice
lack
studi
use
mice
carri
howev
research
still
need
studi
screen
stage
therefor
confirm
use
sirna
pilot
studi
believ
detail
research
need
knockout
anim
model
second
dose
cp
human
g
daili
accord
human
equival
dose
calcul
bodi
weight
kg
correspond
human
dose
extract
cp
mgday
among
unpublish
studi
evalu
safeti
cp
extract
use
standard
toxicolog
studi
design
assess
potenti
oral
dose
toxic
studi
period
week
mice
oral
administ
daili
dose
mgkgday
cp
extract
sever
studi
paramet
mortal
clinic
sign
chang
bodi
weight
gross
find
organ
weight
histopatholog
examin
hematolog
assess
demonstr
cp
extract
advers
effect
mice
dose
mgkgday
administr
period
data
shown
human
equival
dose
calcul
mgday
lower
mgkgday
mgday
human
cp
extract
use
unpublish
studi
therefor
studi
provid
import
refer
safeti
cp
extract
human
howev
detail
research
clinician
avail
studi
conduct
lastli
identifi
activ
compound
cp
respons
antipd
effect
studi
mainli
analyz
separ
catecholamin
compound
focus
variou
neurohormon
chang
insect
metamorphosi
supplementari
fig
expect
larg
amount
neurohormon
releas
left
skin
insect
extermin
howev
sinc
studi
pilot
screen
studi
think
research
need
reveal
accur
mechan
futur
studi
need
analyz
specif
contribut
variou
activ
compound
cp
conclus
demonstr
cp
increas
express
regul
protein
th
ddc
dat
vitro
vivo
figur
cp
protect
dopaminerg
neuron
mptpinduc
neurotox
via
regul
mitochondriamedi
apoptot
molecul
bax
cytc
cleav
parp
neuroinflammatori
signal
molecul
cytokin
ino
glialmicrogli
activ
find
suggest
cp
might
contribut
neuroprotect
signal
regul
neurotroph
factor
via
mitochondriamedi
apoptosi
neuroinflamm
